首页 > 市场调查报告书 > 医疗设备

整形外科

市场调查报告书

商品编码

1673880

关节内粘稠补充疗法市场（按剂量、关节炎类型、最终用户和地区划分）

Viscosupplementation Market, By Dosage, By Arthritis Type, By End User, By Geography

出版日期: 2025年02月12日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球关节内粘稠补充疗法市场规模估计为 41.5 亿美元，预计到 2032 年将达到 71.1 亿美元，2025 年至 2032 年的复合年增长率为 8.0%。

报告范围		报告详细信息
基准年	2024	2025 年市场规模	41.5亿美元
效能资料	2020-2024	预测期	2025-2032
预测期：2025 年至 2032 年复合年增长率	8.00％	2032 年金额预测	71.1亿美元

数字。 2025 年关节内粘稠补充疗法的市场占有率（按地区划分）

关节内粘稠补充疗法是一种用于治疗膝关节骨性关节炎疼痛的整形外科治疗方法。将玻尿酸（又称玻尿酸）注射至膝关节内。玻尿酸可作为关节的润滑剂和避震器。透明质酸可以补充因骨关节炎而降低的关节中的透明质酸水平。这有助于透过增加骨关节炎膝盖滑液的黏度来减轻疼痛并改善活动能力。关节内粘稠补充疗法是一种非手术治疗方法，可以长期缓解膝关节骨性关节炎的症状。

市场动态

全球关节内粘稠补充疗法市场的发展受到日益增长的老年人口的推动，老年人容易患膝关节骨性关节炎和相关的关节疼痛。据估计，目前全球有超过3.3亿人患有骨关节炎。预计未来几年这一数字还将大幅增加。此外，人们对先进的非侵入性治疗方法的认识不断提高，以及关节内粘稠补充疗法的优惠报销计划也在推动市场的发展。然而，对膳食补充剂等替代治疗方法的偏好以及透明质酸注射提供的止痛效果和持续时间有限可能会抑制市场的成长。 3D 列印和机器人技术相结合来开发针对特定患者的透明质酸配方为该市场带来了丰厚的机会。

研究的主要特点

本研究报告对全球关节内粘稠补充疗法市场进行了详细分析，并给出了预测期（2025-2032）的市场规模和年复合成长率（CAGR%），假设 2024 年为基准年。
它揭示了各个领域的潜在商机并解释了该市场的引人注目的投资提案矩阵。
它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
它根据公司亮点、产品系列、关键亮点、绩效和策略等参数，介绍了全球关节内粘稠补充疗法主要企业的概况。
本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球关节内粘稠补充疗法市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
相关人员可以透过分析全球关节内粘稠补充疗法市场所使用的各种策略矩阵来更轻鬆地做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 4.15 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.00%	2032 Value Projection:	USD 7.11 Bn

Viscosupplementation is an orthopedic treatment method used to manage osteoarthritis knee pain. It involves injecting hyaluronic acid, also known as hyaluronan, into the knee joint. Hyaluronic acid acts as a lubricant and shock absorber in the joints. It replenishes levels in the joint that diminish with osteoarthritis. This helps reduce pain and improve mobility by supplementing the viscous nature of the synovial fluid in knees affected by osteoarthritis. Viscosupplementation therapy is a non-surgical treatment option that provides relief from knee osteoarthritis symptoms for extended periods of time.

Market Dynamics:

The global viscosupplementation market is driven by the rising geriatric population which is more prone to develop osteoarthritis and the associated joint pains. As per estimates, over 330 million people currently suffer from osteoarthritis globally. This is projected to increase substantially in the coming years. Moreover, growing awareness about advanced non-invasive treatment alternatives and favorable reimbursement policies for viscosupplementation procedures are boosting the market. However, the market growth can be restrained by the preference for alternative treatment methods like dietary supplements and limitations in the efficacy and duration of pain relief provided by hyaluronic acid injections. The integration of 3D printing and robotic technologies to develop patient-specific hyaluronic acid formulations provides lucrative opportunities in this market.

Key Features of the Study:

This report provides in-depth analysis of the global viscosupplementation market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global viscosupplementation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study includes Anika Therapeutics Inc., Seikagaku Corporation, Ferring Pharmaceuticals, Bioventus, Fidia Farmaceutici S.P.A., Mylan N.V., Sanofi S.A., OrthogenRx, Teva Pharmaceutical Industries Ltd, Johnson & Johnson., F. Hoffmann-La Roche AG, Zimmer Biomet, Aptissen, Wellchem Pharmaceuticals Pte Ltd., Juniper Biologics, and Ono Pharmaceutical Co., Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global viscosupplementation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global viscosupplementation market.

Market Segmentation

Dosage:
- Single Injection
- Three Injection
- Five Injection
Arthritis Type:
- Osteoarthritis
- Rheumatoid Arthritis
End User:
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Company Profiles:
- Anika Therapeutics Inc.
- Seikagaku Corporation
- Ferring Pharmaceuticals
- Bioventus
- Fidia Farmaceutici S.P.A.
- Mylan N.V.
- Sanofi S.A.
- OrthogenRx
- Teva Pharmaceutical Industries Ltd
- Johnson & Johnson.
- Hoffmann-La Roche AG
- Zimmer Biomet
- Aptissen
- Wellchem Pharmaceuticals Pte Ltd.
- Juniper Biologics
- Ono Pharmaceutical Co., Ltd

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Dosage
- Market Snapshot, By Arthritis Type
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
Regulatory Scenario
PEST Analysis

4. Global Viscosupplementation Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Impact on Supply and Demand
COVID-19 Impact on the Market

5. Global Viscosupplementation Market, By Dosage, 2020 - 2032, (US$ Billion)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Single Injection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Three Injection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Five Injection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

6. Global Viscosupplementation Market, By Arthritis Type, 2020 - 2032, (US$ Billion)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Osteoarthritis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Rheumatoid Arthritis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Global Viscosupplementation Market, By End User, 2020 - 2032, (US$ Billion)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Ambulatory Surgical Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

8. Global Viscosupplementation Market, By Region, 2020 - 2032, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2020-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- U.S.
- Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (US$ Billion)
- North Africa
- Central Africa
- South Africa

9. Competitive Landscape

Anika Therapeutics Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Seikagaku Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Ferring Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bioventus
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Fidia Farmaceutici S.P.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
ORTHOGENRX
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Johnson & Johnson
F. Hoffmann-La Roche AG
Zimmer Biomet
Aptissen
Wellchem Pharmaceuticals Pte Ltd.
Juniper Biologics
Ono Pharmaceutical Co., Ltd

10. Analyst View

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

关节内粘稠补充疗法市场（按剂量、关节炎类型、最终用户和地区划分）